Orchid Pharma Analyst Rating
based on 3 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 3 analysts offering long term price targets for Orchid Pharma. An average target of ₹1545.33
Source: S&P Global Market Intelligence
Orchid Pharma Share analysis
Orchid Pharma price forecast by 3 analysts
Downside of
High
₹1710
Target
₹1545.33
Low
₹1285
Orchid Pharma target price ₹1545.33, a slight downside of -6.35% compared to current price of ₹1544.4. According to 3 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Orchid Pharma revenue growth forecast
Expected growth rate Q1, FY2027:169.10%
Forecast
Actual
Including amortisation and stock based compensations
Orchid Pharma EPS growth forecast
EPS estimate Q1, FY2027:370.56%
Forecast
Actual
Source: S&P Global Market Intelligence
Orchid Pharma Performance
Day's Low
Day's High
₹1,536.6Day's Price Range₹1,67052 Week's Low
52 Week's High
₹702.7552-Week Price Range₹1,997.4
| Returns % | |
| 1 Month Return | -4.43 % |
| 3 Month Return | + 25.68 % |
| 1 Year Return | + 128.86 % |
| Market Stats | |
| Previous Close | ₹1,650.05 |
| Open | ₹1,641.60 |
| Volume | 57.15K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹8,368.91Cr |
Orchid Pharma Key Statistics
| P/E Ratio | 68.33 |
| PEG Ratio | 41.41 |
| Market Cap | ₹8,368.91 Cr |
| P/B Ratio | 4.61 |
| EPS | 18.74 |
| Dividend Yield | 0 |
| Sector | Pharmaceuticals |
| ROE | 3.15 |
Orchid Pharma Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹8,368.91 Cr | 1813.39% | 0.55 | ₹95 Cr | ₹819 Cr | |
| NA | ₹271.68 Cr | 110.1% | 0.52 | ₹16 Cr | ₹108 Cr | |
| NA | ₹2,152.42 Cr | 5.69% | 0.52 | NA | NA | |
| NA | ₹142.69 Cr | 3.78% | 0.59 | NA | NA | |
| NA | ₹93.75 Cr | 10.89% | 0.54 | NA | NA |
About Orchid Pharma
Share Price: ₹1544.40 per share as on 21 Jan, 2025 04:01 PM
Market Capitalisation: ₹8,368.91Cr as of today
Revenue: ₹222.70Cr as on September 2024 (Q3 24)
Net Profit: ₹25.90Cr as on September 2024 (Q3 24)
Listing date: 12 May, 1995
Chairperson Name: Ram Gopal Agarwal
| Organisation | Orchid Pharma |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Orchid Pharma Ltd
Orchid Pharma Stock Declines After Six-Day Gain - 06 Jan, 2025
Orchid Pharma's stock fell by 5.34% on January 6, 2025, after a six-day gain streak. Despite this decline, it has increased by 6.45% over the past month, outperforming the Sensex, which decreased by 2.85%. The stock is currently rated as a Hold by MarketsMOJO.Orchid Pharma Reaches 52-Week High with Strong Gains - 03 Jan, 2025
On January 3, 2025, Orchid Pharma's stock surged by 5.71%, hitting a 52-week high of Rs. 1968.95. The stock has outperformed its sector and has shown consistent gains over the past four days, totaling an 8.78% return. Additionally, it has risen by 17.72% in the last month.Orchid Pharma Hits New 52-Week High - 02 Jan, 2025
On January 2, 2025, Orchid Pharma reached a new 52-week high of Rs. 1874.75, following three days of gains. The stock opened 2.75% higher and has delivered impressive returns of 149.82% over the past year, outperforming the Sensex.Orchid Pharma Hits 52-Week High with Strong Growth - 27 Dec, 2024
On December 27, 2024, Orchid Pharma's stock reached a 52-week high of Rs. 1850, marking a 4.32% daily increase and a remarkable 155.49% growth over the past year, significantly outperforming the Sensex.
Insights on Orchid Pharma Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRetail Holding Up
Retail Investor have increased holdings from 9.81% to 9.93% in Sep 2024 quarter
- POSITIVE IMPACT
Price Rise
In the last 1 year, ORCHPHARMA stock has moved up by 129.0%
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, ORCHPHARMA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, ORCHPHARMA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 1.42% to 1.94% in Sep 2024 quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 69.84% of holdings in Sep 2024 quarter
NEGATIVE IMPACTMF Holding Down
Mutual Funds have decreased holdings from 16.91% to 16.78% in Sep 2024 quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 251.98 Cr → 230.22 Cr (in ₹), with an average decrease of 8.6% per quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, 32.96 Cr → 27.24 Cr (in ₹), with an average decrease of 9.1% per quarter
Orchid Pharma Financials
Index Inclusions
Orchid Pharma Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 69.84% | 0.00 | |
| Foreign Institutions | 1.94% | 36.07 | |
| Mutual Funds | 16.78% | ||
| Retail Investors | 9.93% | 1.23 | |
| Others | 1.51% |
Orchid Pharma Key Indicators
Orchid Pharma Valuation
Orchid Pharma in the last 5 years
Lowest (-871.56x)
April 8, 2022
Industry (55.28x)
January 20, 2025
Today (68.33x)
January 20, 2025
Highest (105.04x)
September 14, 2022
Orchid Pharma Earnings and Dividends
Orchid Pharma Ltd Earnings Results
Orchid Pharma Ltd’s net profit jumped 37.58% since last year same period to ₹27.24Cr in the Q2 2024-2025. On a quarterly growth basis, Orchid Pharma Ltd has generated -7.19% fall in its net profits since last 3-months.
Read More about Earnings Results
Orchid Pharma Technicals Summary
Bearish
Neutral
Bullish
Orchid Pharma Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Orchid Pharma Ltd
Orchid Pharma Ltd share price today stands at ₹1544.4, Open. ₹1641.6 ; Previous Close. ₹1650.05 ; High. ₹1670 ; Low. ₹1536.6 ; 52 Week High. ₹1997.4 ; 52 Week Low: ₹702.75.
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Orchid Pharma Ltd shares.
Orchid Pharma Ltd is listed on NSE
Orchid Pharma Ltd is listed on BSE
- Today’s highest price of Orchid Pharma Ltd is ₹1670.
- Today’s lowest price of Orchid Pharma Ltd is ₹1536.6.
PE Ratio of Orchid Pharma Ltd is 68.33
PE ratio = Orchid Pharma Ltd Market price per share / Orchid Pharma Ltd Earnings per share
Today’s traded volume of Orchid Pharma Ltd(ORCHPHARMA) is 57.15K.
Today’s market capitalisation of Orchid Pharma Ltd(ORCHPHARMA) is ₹8368.91Cr.
| Orchid Pharma Ltd(ORCHPHARMA | Price |
|---|---|
52 Week High | ₹1997.4 |
52 Week Low | ₹702.75 |
Orchid Pharma Ltd(ORCHPHARMA) share price is ₹1544.4. It is down -22.68% from its 52 Week High price of ₹1997.4
Orchid Pharma Ltd(ORCHPHARMA) share price is ₹1544.4. It is up 119.77% from its 52 Week Low price of ₹702.75
| Orchid Pharma Ltd(ORCHPHARMA | Returns |
|---|---|
1 Day Returns | -105.65% |
1 Month Returns | -4.43% |
3 Month Returns | 25.68% |
1 Year Returns | 128.86% |